Similasan Graphites compositum, Augentropfen

7680693280014 CH-69328 20.01.1.
Similasan Graphites compositum, Augentropfen
Similasan Graphites compositum, Augentropfen
Similasan Graphites compositum, Augentropfen
1 / 3
google

Details

Product number
6932801
CPT
-
Packaging group
10
Unit
ml
Composition
conium maculatum (HAB) D6 0.227 ml, graphites (HAB) D12 0.227 ml, sulfur (HAB) D12 (HAB SV) 0.227 ml, argentum nitricum (HAB) D6 0.227 ml, acidum boricum, borax, natrii nitras, aqua ad iniectabile, ad solutionem pro 1 ml, corresp. 25 guttae.

Articles (1)

Similasan Graphites compositum, Augentropfen
Augentropfen
10
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
0.227 ML Substance Wirkstoff (Principe actif)
(N/A)
0.227 ML Substance Wirkstoff (Principe actif)
(N/A)
0.227 ML Substance Wirkstoff (Principe actif)
(N/A)
0.227 ML Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

T&S Eye Care Management AG

6060 Sarnen

Authorization information

Swissmedic authorization number
69328
Drug name
Similasan Graphites compositum, Augentropfen
Galenic form
AUL
Authorization status
Z
Dispensation category
D
First authorization
14/06/2024
Authorization expiration date
13/06/2029
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild unterstützend bei Gersten- und Hagelkörnern mit leicht entzündeten, geschwollenen Stellen am Augenlid

Packaging details

Description (FR)
SIMILASAN Graphites compositum gtt opht 0.227 ml 1
Description (DE)
SIMILASAN Graphites compositum Trp Opht 0.227 ml 1
Market launch
15/01/2026
Narcotic (BTM)
No